Setiba Medical Group Beauty And Med Spa In Westlake Village Skip to main content

Melamix™ Skin Lightener & Blending Crème

Formulated specifically to be used with tretinoin. Contains 4% hydroquinone, which is used for the treatment of pigmentation.

Categories: ,

Description

80 g / 2.8 Oz.

Formulated specifically to be used with tretinoin. Contains 4% hydroquinone, which is used for the treatment of pigmentation.

BENEFITS

  • Helps even skin tone
  • Helps optimize delivery of active ingredients
  • Helps reduce irritation associated with hydroquinone
  • Hydrates newly exposed skin

DIRECTIONS FOR USE

Apply 2 pumps to affected areas twice a day or as directed by a physician. Always follow with sunscreen protection. See enclosed package insert for full prescribing information.

BEFORE + AFTER

  • Diagnosis: Melasma & Rosacea
  • Treatment: ZO® Multi-Therapy Hydroquinone System
  • Duration: 5 months

ADVANCED INFORMATION

  • 4% hydroquinone: Suppresses pigment production
  • Glycolic acid and ascorbic acid: Purges surface pigmentation
  • Glycerin: Hydrates newly exposed skin
  • Saponins: Modulates inflammatory response
  • Vitamin E and butylated hydroxytoluene: Provides antioxidant properties
  • Ethylhexyl palmitate: Skin conditioner, barrier restoration
  • Phenyl trimethicone: Barrier film, penetration enhancement

INGREDIENTS

Active Ingredient: Hydroquinone 4%
Inactive Ingredients: Water, Cetyl Alcohol, Glycerin, Ethylhexyl Palmitate, Sodium Lauryl Sulfate, Stearyl Alcohol, Helianthus Annuus (Sunflower) Seed Oil, Maltodextrin, Phenyl Trimethicone, Tocopheryl Acetate, Phenoxyethanol, Ascorbic Acid, Aminopropyl Dihydrogen Phosphate, Beta-Glucan, Sodium Metabisulfite, Glycolic Acid, Brassica Oleracea Italica (Broccoli) Sprout Powder, Ascorbyl Palmitate, Chlorphenesin, Caprylyl Glycol, Disodium EDTA, Stachys Officinalis Flower/Leaf/Stem Extract, Saponins, Sodium Sulfite.

Reviews

There are no reviews yet.

Be the first to review “Melamix™ Skin Lightener & Blending Crème”

Your email address will not be published. Required fields are marked *